Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
European Journal of Pharmacology
|
December 16, 1998
Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat
E Lazartigues, J L Freslon, T Tellioglu, et al.
Parkinsonism & Related Disorders
|
December 20, 2017
Abnormal pain perception in patients with Multiple System Atrophy
F Ory-Magne, J Pellaprat, E Harroch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 1, 1998
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy
O Rascol, K Sieradzan, H Peyro-Saint-Paul, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 15, 2010
Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease
V Marchand-Pauvert, A Gerdelat-Mas, F Ory-Magne, et al.
European Journal of Neurology
|
April 19, 2006
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers
J J Ferreira, K Desboeuf, M Galitzky, et al.
Revue Neurologique
|
June 22, 2021
Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulation
B Fernández-Rodríguez, J Dupouy, E Harroch, et al.
Stereotactic and Functional Neurosurgery
|
January 28, 2004
Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contacts
P Cintas, M Simonetta-Moreau, F Ory, et al.
Neurology
|
September 30, 2010
Motor activation in multiple system atrophy and Parkinson disease: a PET study
P Payoux, C Brefel-Courbon, F Ory-Magne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
O Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Journal of Neuropathology and Experimental Neurology
|
April 22, 2004
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene
R Vidal, B Ghetti, M Takao, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
European Journal of Pharmacology
|
December 16, 1998
Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat
E Lazartigues, J L Freslon, T Tellioglu, et al.
Parkinsonism & Related Disorders
|
December 20, 2017
Abnormal pain perception in patients with Multiple System Atrophy
F Ory-Magne, J Pellaprat, E Harroch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 1, 1998
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy
O Rascol, K Sieradzan, H Peyro-Saint-Paul, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 15, 2010
Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease
V Marchand-Pauvert, A Gerdelat-Mas, F Ory-Magne, et al.
European Journal of Neurology
|
April 19, 2006
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers
J J Ferreira, K Desboeuf, M Galitzky, et al.
Revue Neurologique
|
June 22, 2021
Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulation
B Fernández-Rodríguez, J Dupouy, E Harroch, et al.
Stereotactic and Functional Neurosurgery
|
January 28, 2004
Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contacts
P Cintas, M Simonetta-Moreau, F Ory, et al.
Neurology
|
September 30, 2010
Motor activation in multiple system atrophy and Parkinson disease: a PET study
P Payoux, C Brefel-Courbon, F Ory-Magne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
O Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Journal of Neuropathology and Experimental Neurology
|
April 22, 2004
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene
R Vidal, B Ghetti, M Takao, et al.
Page
of 5